Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Menopause affects hair and skin; more research needed for treatment.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Using neurohormones to control keratin can lead to new skin disease treatments.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Calcium is important for stem cell function and maintenance, especially in blood and skin cells.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Light microscopy is useful for diagnosing different hair disorders.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.